Decitas 30 mg Injection
$40,37
$34,62
Decitas 30 mg Injection is a targeted anti-cancer therapy specifically designed to address myelodysplastic syndromes, a category of disorders characterized by the ineffective production of healthy blood cells in the bone marrow. These conditions lead to an overproduction of immature cells, known as blasts, which can compromise overall health. By administering Decitas, patients may experience improved blood cell production, as the medication works to restore balance and functionality within the bone marrow. It's crucial for patients to discuss any potential side effects and contraindications with their healthcare provider before starting treatment, as Decitas can interact with other medications and may not be suitable for everyone. Regular monitoring and follow-up care are essential to ensure optimal results and manage any adverse reactions. With its innovative approach to treating myelodysplastic syndromes, Decitas represents a significant advancement in oncology care, providing hope to those affected by these challenging conditions. Always consult with a medical professional for personalized advice and treatment options.
數量
Active Pharmaceutical Ingredient
Uses
• Decitas 30 mg injection is primarily utilized in the treatment of myelodysplastic syndrome (MDS). This condition arises when the bone marrow produces abnormal blood cells, leading to a decrease in healthy blood cell counts. Patients may experience symptoms such as fatigue, weakness, and easy bruising. Administering Decitas 30 mg injection can help manage these symptoms and improve the quality of life for those affected.
• Another significant application of Decitas 30 mg injection is in the management of acute myeloid leukemia (AML). AML is a type of cancer that impacts the myeloid cells, which play a critical role in blood cell production. The injection works to inhibit the progression of this aggressive form of blood cancer. By using Decitas 30 mg injection, healthcare providers aim to reduce symptoms like fatigue and frequent infections associated with AML.
• Decitas 30 mg injection may also be indicated for patients with relapsed or refractory cases of myelodysplastic syndrome. In these situations, the disease does not respond to standard treatments, necessitating alternative therapeutic options. The use of Decitas 30 mg injection can offer renewed hope for patients facing these challenging scenarios. It is designed to target the underlying issues of abnormal blood cell production in MDS.
• In clinical settings, Decitas 30 mg injection is often part of a comprehensive treatment plan for patients with hematologic malignancies. By effectively addressing the underlying conditions of myelodysplastic syndrome and acute myeloid leukemia, this medication plays a crucial role in improving patient outcomes. The injection is administered under professional supervision to ensure optimal management of the disease. Through its targeted action, Decitas 30 mg injection aids in restoring balance to the patient’s blood cell production.
Benefits
Myelodysplastic syndrome: Decitas 30 mg Injection is used to treat myelodysplastic syndrome, a group of conditions in which the bone marrow produces blood cells that are abnormal in structure and function and does not produce enough healthy blood cells. Decitas Injection kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Acute myeloid leukemia (AML): Decitas 30 mg is used to treat acute myeloid leukemia, a type of blood cancer that affects the white blood cells, specifically, the myeloid cells, which are responsible for producing red blood cells, platelets, and other white blood cells. In AML, the myeloid cells become abnormal and do not function properly, leading to a decrease in healthy blood cells and an increase in abnormal cells. Decitas Decitabine Vial kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells.
Side Effects
Most adverse effects do not require medical attention and will go away when your body gets used to the medicine. Inform your doctor if any of these symptoms get severe or that bother you for a longer period.
Most Common Side Effects
• Insomnia
• Nausea
• Constipation
• Diarrhoea
• Vomiting
• Stomach pain
• Painful sores in mouth or tongue or lips
• Indigestion
• Heartburn
• Rashes
• Itching
• Hair loss
• Skin discolouration
• Chest discomfort
• Muscle pain
• Joint pain
• Swelling over extremities
• Pain or swelling or redness over the injection site
• Weakness
• Confusion
• Headache
• Dizziness
• Extreme weakness
Common Side Effects
• Bruising
• Unusual bleeding
• Facial swelling
• Respiratory distress, breathing difficulty, rapid breathing, tachypnoea
• Sore throat
• High
• grade fever with chills
• Other signs of infection
How To Use
Decitas 30 mg Injection is available in powder form, which must be diluted and administered into the vein (IV) slowly as directed by your doctor. Decitas Cancer Injection is administered by a doctor or nurse at a hospital or clinical setting. The dosage, frequency, and interval (duration of infusion) depend upon your medical condition, body size, lab test results, and response towards the treatment given. Don't administer this drug by yourself; it must be administered under medical supervision by health care professionals only. It may take several weeks or months for you to see or feel the benefits, but do not stop taking it unless your doctor tells you to. You should avoid drinking alcohol, as it may increase your risk of liver damage. Do not self-administer this Decitas Injection.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Decitas 30 mg. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Decitas 30 mg Injection is safe for use in patients with mild to moderate kidney disease; no dose adjustment of Decitas Injection is recommended. The use of the Decitas 30 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Decitas Decitabine Vial. Decitas 30 mg Injection may pass into breast milk and harm the infant. If you are breastfeeding and taking Decitas Cancer Injection, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Decitas 30 mg Injection is recommended for use in patients with mild to moderate liver disease. No dose adjustment is needed in such types of patients. In case patients suffer from severe liver disease, the use of this medicine in such types of people is not recommended; it may worsen the patient's condition.
• Pregnancy: Use of Decitas Cancer Injection may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Decitas 30 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Decitabine 30 mg Injection may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery, if you suffer from the side effects of this Decitas 30 mg.